In this sense, a recent meta-analysis reported a significant association between increased levels of HMGA2 and later tumor stage, lymph node metastasis, vascular invasion, and diminished overall survival of gastric cancer patients, thus pointing out its potential role as a prognostic biomarker for gastric tumors [62]. This evidence concerns the gene HMGA2 and gastric cancer.